FDA Launches Rare Disease Framework Initiative to Modernize Small-Cohort Trial Design

To begin shaping the detailed regulations, revised guidances, and internal reviewer training modules, the FDA will convene a major public stakeholder summit on October 28 at its White Oak headquarters in Silver Spring, Maryland, facilitated by the Reagan-Udall Foundation.